Contributed by Etiometry
Cardiogenic shock (CS) remains one of the most fatal complications in cardiac care, characterized by critically reduced cardiac output and subsequent end-organ hypoperfusion. Despite advances in interventional cardiology, mortality remains high.
Learn how AI is redefining the management of cardiogenic shock—enhancing early detection, risk stratification, and clinical decision-making.
Download Etiometry’s latest whitepaper here.
About Etiometry
Founded in 2010, Etiometry is the leader in clinical decision-support software designed to help clinicians in the intensive care setting make data-based decisions regarding their patients’ care and treatment. The company’s technologies provide valuable clinical insight and analysis to support early recognition of subtle changes in patients’ conditions to avoid complications and speed recovery.
Etiometry has nine FDA clearances and four Health Canada approvals and CE markings. Etiometry is utilized by some of the world’s top academic medical centers as well as leading children’s hospitals ranked by US News and World Report and Newsweek. Etiometry is committed to improving patient outcomes, increasing clinical efficiency, and lowering the cost of care through the more effective use of data.
The Etiometry Platform is the only critical care software solution that reveals deep insights into patient physiology, helping critical care teams deliver standardized and individualized care – and provides the ability to automate care escalation and de-escalation decisions. It is designed to facilitate the use of all available data to support the anticipation and management of the dynamic condition of patients requiring intensive care.
To learn more, visit etiometry.com.
